The IL-1 Family Controls Acute Mucosal Fungal Infection and Mucosal-Systemic Dissemination.

This study demonstrates that the IL-1 family is essential for initiating mucosal immunity against *Candida albicans* by regulating antimicrobial peptides and neutrophil responses, thereby preventing local infection from progressing to fatal systemic dissemination, particularly in neutropenic patients.

The Gist

The Big Picture: A Castle Under Siege

Imagine your mouth is a fortress (the mucosal barrier) and Candida albicans (a common yeast) is an invading army. Usually, this army is harmless and just hangs out in the castle's courtyard. But if the castle's defenses are weak, the army can grow out of control, break through the walls, and invade the rest of the kingdom (your bloodstream and organs), which can be fatal.

This paper asks a crucial question: What are the specific alarm bells and defense mechanisms that stop the invaders from breaking out of the mouth and spreading to the rest of the body?

The researchers discovered that a specific group of chemical messengers, called the IL-1 Family, acts as the fortress's "Early Warning System."

---

The Key Players

1. The Invader (Candida albicans): A yeast that can turn into a dangerous pathogen. It has a secret weapon called Candidalysin, which is like a sledgehammer that smashes the castle walls.
2. The Alarm System (IL-1 Family): A team of chemical signals (IL-1α, IL-1β, IL-33, IL-36) that scream "We are under attack!" the moment the sledgehammer hits the wall.
3. The Elite Guard (Neutrophils): The body's rapid-response soldiers. They rush to the scene to eat the invaders.
4. The Reinforcements (IL-17 & T-cells): The generals that organize the long-term defense and tell the soldiers where to go.

---

The Story of the Experiment

1. The Trigger: The Sledgehammer

The researchers found that the yeast doesn't just sit there; it uses its sledgehammer (Candidalysin) to damage the mouth cells. This damage is what triggers the IL-1 Alarm System. Without the sledgehammer, the alarm doesn't go off.

2. The Broken Alarm (The IL-1 Deficient Mice)

The scientists created a group of mice that were missing the IL-1 Alarm System.

• What happened? When these mice were infected, the alarm never rang. The yeast grew unchecked, smashing through the mouth walls and causing severe damage.
• The Silver Lining: Even without the alarm, the mice eventually survived. Why? Because the Elite Guard (Neutrophils) eventually showed up on their own, albeit late. They arrived in such huge numbers (like a massive backup crew arriving after the party has already started) that they managed to clean up the mess and stop the infection.

3. The Double Disaster (The "Perfect Storm")

Here is where it gets scary. The researchers looked at patients who are already weak, specifically those with neutropenia (a condition where they have very few or no neutrophils). This is common in cancer patients undergoing chemotherapy.

They created a scenario where the mice had both a broken alarm system (no IL-1) and no Elite Guard (no neutrophils).

• The Result: Total catastrophe.
• Without the alarm to call for help, and without the soldiers to fight, the yeast didn't just stay in the mouth. It broke through the walls, traveled through the bloodstream, and invaded the liver, spleen, and brain.
• The Outcome: The mice died. This perfectly mimics what happens to vulnerable human patients who get invasive fungal infections.

4. The "One-Is-Enough" Rule

The most important discovery is that the body has a redundancy system (a backup plan).

• Scenario A: If you have the Alarm (IL-1) but no Soldiers (Neutrophils), the Alarm calls for help, and the infection is contained.
• Scenario B: If you have the Soldiers (Neutrophils) but no Alarm (IL-1), the Soldiers eventually show up on their own and save the day.
• Scenario C: If you have neither, the fortress falls, and the infection spreads to the whole kingdom.

The "Aha!" Moment

The paper reveals that the IL-1 Family is the critical "risk factor" for life-threatening disease.

Think of it like a fire in a house:

• IL-1 is the Smoke Detector.
• Neutrophils are the Firefighters.
• If the smoke detector is broken, the firefighters might still show up eventually if they smell the smoke themselves.
• If the firefighters are on vacation, the smoke detector can still call the fire department.
• But if the smoke detector is broken AND the firefighters are on vacation, the house burns down.

Why This Matters for Humans

This study explains why some patients with weak immune systems (like those with cancer or HIV) get deadly fungal infections while others don't. It suggests that if a patient has a genetic weakness in their IL-1 signaling (their smoke detector is broken), they are at extreme risk if they also lose their neutrophils (firefighters).

The Takeaway:
Doctors might be able to use this knowledge to:

1. Identify high-risk patients: Check if a patient has weak IL-1 signaling before they start chemotherapy.
2. Develop new treatments: Instead of just killing the fungus, we could try to "boost the smoke detector" (enhance IL-1 signaling) to help the body fight back, especially in patients who are missing their firefighters.

In short, the IL-1 Family is the unsung hero that keeps the fungal infection locked in the mouth, working hand-in-hand with our immune cells to prevent a small problem from becoming a life-or-death emergency.

Technical Summary

1. Problem Statement

Candida albicans is a major opportunistic fungal pathogen responsible for significant global morbidity and mortality. While it typically exists as a commensal organism, it can cause superficial mucosal infections (e.g., oropharyngeal candidiasis, OPC) and, in immunocompromised hosts (such as those with neutropenia), breach mucosal barriers to cause life-threatening systemic dissemination (invasive candidiasis).

Despite the known role of the IL-1 family in immunity, the specific mechanisms by which the host controls acute mucosal infection and prevents systemic dissemination remain unclear. Furthermore, it is not fully understood how the interplay between IL-1 family signaling and neutrophil recruitment dictates the transition from localized mucosal infection to fatal systemic disease.

2. Methodology

The study employed a combination of in vitro human cell models and in vivo murine models to dissect the immune response to C. albicans.

• In Vitro Models:

  • Cell Line: TR146 human oral epithelial cells were infected with wild-type C. albicans (BWP17+CIp30), a candidalysin-deficient mutant (ece1Δ/Δ), and a revertant strain.
  • Stimulation: Cells were also treated with synthetic candidalysin at varying concentrations.
  • Analysis: Bulk RNA sequencing (RNA-Seq) was performed at 4 hours post-infection to identify upregulated immune pathways, specifically focusing on IL-1 family members, TLRs, and CLRs.

• In Vivo Models:

  • Mouse Strains: Wild-type (C57BL/6J) and IL-1 receptor accessory protein-deficient mice (IL-1RAcP-/-), which lack signaling for IL-1α, IL-1β, IL-33, and IL-36.
  • Infection Model: Sublingual challenge with wild-type C. albicans (strain AHY940) or the ece1Δ/Δ mutant to induce OPC.
  • Interventions:
    • Neutropenia: Induced via anti-Ly6G antibody administration to deplete neutrophils.
    • Pharmacological Blockade: Treatment with Anakinra (IL-1R antagonist) or anti-IL-17A antibodies in neutropenic wild-type mice.
  • Readouts:
    • Fungal Burden: Quantification of Colony Forming Units (CFU) in tongue, liver, spleen, kidney, brain, and gastrointestinal tract.
    • Histology: PAS and H&E staining to assess tissue invasion and inflammation.
    • Gene Expression: RT-qPCR for antimicrobial peptides (AMPs), cytokines (IL-17, IL-22, IL-23), and chemokines.
    • Flow Cytometry: Analysis of immune cell infiltration (neutrophils, TCRαβ+, TCRγδ+ cells) in tongue tissue and bone marrow.

3. Key Contributions

• Identification of Candidalysin as the Primary Trigger: The study confirms that the fungal toxin candidalysin is the critical driver for the rapid induction of the IL-1 family (IL-1α, IL-1β, IL-33, IL-36γ) in mucosal epithelial cells, while TLR and CLR pathways are not significantly induced in the acute phase.
• Definition of the IL-1/Neutrophil Redundancy Axis: The paper establishes a cooperative, redundant protective mechanism where the IL-1 family and neutrophils function as a "two-layer" defense. If one layer is compromised, the other can eventually resolve the infection; if both are absent, dissemination occurs.
• Novel Mouse Model of Dissemination: The authors successfully modeled mucosal-to-systemic dissemination in mice by combining IL-1RAcP deficiency with neutropenia. This mimics the clinical progression seen in severely immunocompromised human patients, a feat difficult to achieve with standard intravenous infection models.
• Mechanism of Barrier Breach: The study demonstrates that the absence of IL-1 signaling leads to a failure in early AMP production and delayed neutrophil recruitment, allowing C. albicans to invade deep into the mucosa and translocate to the liver.

4. Key Results

• IL-1 Family Induction: Infection with wild-type C. albicans rapidly induced IL-1α, IL-1β, IL-33, and IL-36γ in human epithelial cells. This induction was strictly dependent on candidalysin, as the ece1Δ/Δ mutant failed to trigger these pathways.
• Susceptibility of IL-1RAcP-/- Mice:
  • IL-1RAcP-/- mice exhibited severe acute OPC with significantly higher fungal burdens and weight loss compared to wild-type controls at days 1 and 2.
  • Histology revealed deep hyphal invasion and disrupted mucosal barriers in IL-1RAcP-/- mice.
  • Despite this severity, wild-type and IL-1RAcP-/- mice eventually cleared the infection by day 3 due to a delayed but potent neutrophil response.
• Dependence of AMPs and IL-17 on IL-1 Signaling:
  • Early expression of β-defensin 3, calprotectin, and IL-17A/F was abolished in IL-1RAcP-/- mice.
  • Recruitment of innate TCRγδ+ and TCRαβ+ cells was delayed in the absence of IL-1 signaling but recovered by day 2.
• Neutrophil Dynamics:
  • Neutrophil recruitment was delayed in IL-1RAcP-/- mice (10-fold lower at day 1) but surged dramatically by day 2 (100-fold increase), driven by emergency granulopoiesis.
  • This delayed surge was sufficient to clear the infection in immunocompetent IL-1RAcP-/- mice.
• Dissemination and Mortality:
  • Critical Finding: When IL-1RAcP-/- mice were rendered neutropenic, they succumbed to the infection by day 4.
  • Dissemination Pattern: In these double-deficient mice, C. albicans disseminated from the mucosa to the liver (day 3) and subsequently to the spleen, kidney, and brain (day 4). The liver was the primary target, mirroring human clinical disease.
  • Role of Candidalysin in Dissemination: The ece1Δ/Δ mutant (lacking candidalysin) could not disseminate even in neutropenic IL-1RAcP-/- mice, proving that toxin-induced barrier damage is required for systemic spread.
• Specificity of the IL-1 Family: Blocking IL-17 or IL-1R alone in neutropenic wild-type mice did not cause dissemination. Only the combined loss of IL-1 family signaling (via IL-1RAcP-/-) and neutrophils led to systemic spread, highlighting that the combinatorial IL-1 family is the key host risk factor.

5. Significance

• Clinical Relevance: The study identifies the IL-1 family as a critical host risk factor for invasive fungal disease. Patients with genetic polymorphisms leading to deficient IL-1 family signaling may be at high risk for dissemination, particularly if they are also neutropenic (e.g., due to chemotherapy).
• Therapeutic Implications: The findings suggest that therapeutically enhancing IL-1 family signaling could bolster mucosal immunity and prevent life-threatening dissemination in immunocompromised patients. Conversely, it highlights the danger of blocking IL-1 pathways in patients with fungal infections.
• Paradigm Shift: The research challenges the view that IL-17 is the sole driver of mucosal immunity, showing that the upstream IL-1 family is essential for initiating the AMP and neutrophil responses required to contain C. albicans at the mucosal barrier.
• Modeling Advancement: The study provides a robust murine model for studying mucosal-systemic dissemination, addressing a gap in current research where standard models (intravenous injection) fail to capture the mucosal events leading to systemic infection.